Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2005 Sep 20;6(1):E108–E114. doi: 10.1208/pt060117

Spray-dried poly(D,L-lactide) microspheres containing carboplatin for veterinary use: In vitro and in vivo studies

Elisabetla Gavini 1, Lucia Manunta 2, Stefano Giua 2, Giannina Achenza 3, Paolo Giunchedi 1,✉
PMCID: PMC2750418  PMID: 16353954

Abstract

The aim of this study was the development of a veterinary dosage form constituted by injectable biodegradable microspheres designed for the subcutaneous release of carboplatin, a chemotherapeutic drug. Poly(D,L-lactide) (PDLLA) microspheres were prepared by an emulsification/spray-drying method, using the drug-to-polymer weight ratios 1∶9 and 1∶5; blank microspheres (1% w/v) were prepared as a comparison. Microparticles were characterized in terms of morphology, encapsulation efficiency, and in vitro drug release behavior. In vivo tests were conducted on rats by subcutaneous injection of microsphere aqueous suspensions. Levels of carboplatin were evaluated both in the skin and in serum. The microparticles obtained had a spherical shape; particle size ranged from 5 to 7 μm, dependent on drug loading. Microspheres were able to control the in vitro release of the drug: approximately 90% to 100% of the carboplatin was released over 30 days. In vivo results showed that the microspheres were able to release high drug amounts locally, and sustained serum levels of drug were also achieved. Based on these results, carboplatin-loaded PDLLA microspheres may be useful for local delivery of the antineoplastic drug to the tumor, avoiding tumor recurrence in small animals, and may decrease the formation of distant metastases.

Keywords: local chemotherapy; companion animals; poly(D,L-lactide); carboplatin; microspheres; spray-drying

Full Text

The Full Text of this article is available as a PDF (499.8 KB).

References

  • 1.Bergman PJ, MacEwen G, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993) J Vet Intern Med. 1996;10:76–81. doi: 10.1111/j.1939-1676.1996.tb02031.x. [DOI] [PubMed] [Google Scholar]
  • 2.Lana SE, Dernell WE, LaRue SM, et al. Slow release cisplatin combined with radiation for the treatment of canine nasal tumours. Vet Radiol Ultrasound. 1997;38:474–478. doi: 10.1111/j.1740-8261.1997.tb00875.x. [DOI] [PubMed] [Google Scholar]
  • 3.Withrow SJ. Surgical oncology. In: Withrow SJ, MacEwen EG, editors. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders; 2001. pp. 70–75. [Google Scholar]
  • 4.Goldberg EP, Hadba AR, Almond BA, Marotta JS. Intratumoral cancer chemotherapy and immunotherapy:opportunities for nonsystemic preoperative drug delivery. J Pharm Pharmacol. 2002;54:159–180. doi: 10.1211/0022357021778268. [DOI] [PubMed] [Google Scholar]
  • 5.Utsuki T, Brem H, Pitha J, et al. Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl α-cyclodextrin. J Control Release. 1996;40:251–260. doi: 10.1016/0168-3659(95)00192-1. [DOI] [Google Scholar]
  • 6.Chen W, Lu DR. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. J Microencapsul. 1999;16:551–563. doi: 10.1080/026520499288753. [DOI] [PubMed] [Google Scholar]
  • 7.Emerich DF, Winn SR, Hu Y, et al. Injectable chemotherapeutic microspheres and glioma I: Enhanced survival following implantation into the cavity wall of debulked tumours. Pharm Res. 2000;17:767–765. doi: 10.1023/A:1007576405039. [DOI] [PubMed] [Google Scholar]
  • 8.Emerich DF, Winn SR, Hu Y, et al. Injectable chemotherapeutic microspheres and glioma II: Enhanced survival following implantation into deep inoperable tumours. Pharm Res. 2000;17:776–781. doi: 10.1023/A:1007591721877. [DOI] [PubMed] [Google Scholar]
  • 9.Ehrhart N, Dernell WE, Ehrhart EJ, et al. Effects of a controlled-release cisplatin delivery system used after resection of mammary carcinoma in mice. J Am Vet Med Assoc. 1999;60:1347–1351. [PubMed] [Google Scholar]
  • 10.Orenberg EK, Luck EE, Brown DM, Mitchell BE, et al. Implant delivery system: intralesional delivery of chemotherapeutic agents for treatment of spontaneous skin tumors in veterinary patients. Clin Dermatol. 1991;9:561–568. doi: 10.1016/0738-081X(91)90085-Y. [DOI] [PubMed] [Google Scholar]
  • 11.Orenberg EK, Miller BH, Greenway HT, et al. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. J Am Acad Dermatol. 1992;27:723–728. doi: 10.1016/0190-9622(92)70245-B. [DOI] [PubMed] [Google Scholar]
  • 12.Théon AP, Pascoe JR, Carlson GP, Krag DN. Intratumoral chemotherapy with cisplatin in oily emulsion for treatment of tumours in horses. J Am Vet Med Assoc. 1993;202:261–267. [PubMed] [Google Scholar]
  • 13.Théon AP, Pascoe JR, Galuppo LD, Fisher PE, Griffey SM, Madigan JE. Prospective randomised comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous of tumours in horses. J Am Vet Med Assoc. 1999;215:1655–60. [PubMed] [Google Scholar]
  • 14.Théon AP, Vechten MK, Madewell BR. Intratumoral administration of carboplatin for treatment of squamous cell carcinomas of the nasal plane in cats. J Am Vet Med Assoc. 1996;57:205–10. [PubMed] [Google Scholar]
  • 15.Kubo T, Sugita T, Shimose S, Nitta Y, Ikuta Y, Murakami T. Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamicin for osteosarcoma in hamsters. Int J Oncol. 2001;18:121–125. doi: 10.3892/ijo.18.1.121. [DOI] [PubMed] [Google Scholar]
  • 16.Menei P, Venier MC, Gamelin E, et al. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study. Cancer. 1999;86:325–330. doi: 10.1002/(SICI)1097-0142(19990715)86:2<325::AID-CNCR17>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • 17.Pohlen U, Berger G, Binnenhei M, Reszka R, Buhr HJ. Increased carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam): An experimental study in liver tumor-bearing rabbits. J Surg Res. 2000;92:165–170. doi: 10.1006/jsre.2000.5856. [DOI] [PubMed] [Google Scholar]
  • 18.Okada H, Toguchi H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst. 1995;12:1–99. doi: 10.1615/critrevtherdrugcarriersyst.v12.i1.10. [DOI] [PubMed] [Google Scholar]
  • 19.Fu YJ, Mi FL, Wong TB, Shyu SS. Characteristic and controlled release of anticancer drug loaded poly(D,L-lactide) microparticles prepared by spray drying technique. J Microencapsul. 2001;18:733–747. doi: 10.1080/02652040010055649. [DOI] [PubMed] [Google Scholar]
  • 20.Shenoy DB, D'Souza RJ, Udupa N. Poly(DL-lactide-co-glycolide) microporous microsphere-based depot formulation of a peptide-like antineoplastic agent. J Microencapsul. 2002;19:523–535. doi: 10.1080/02652040210141084. [DOI] [PubMed] [Google Scholar]
  • 21.Zhu KJ, Zhang JX, Wang C, Yasuda H, Ichimaru A, Yamamoto K. Preparation and in vitro release behavior of 5-fluorouracil-loaded microspheres based on poly (L-lactide) and its carbonate copolymers. J Microencapsul. 2003;20:731–743. doi: 10.1080/02652040310001600785. [DOI] [PubMed] [Google Scholar]
  • 22.Anderson JM, Matthew SS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:2–24. doi: 10.1016/S0169-409X(97)00048-3. [DOI] [PubMed] [Google Scholar]
  • 23.Page RL, McEntee M, George SL, et al. Pharmacokinetic and phase 1 evaluation of carboplatin in dogs. J Vet Intern Med. 1993;7:235–240. doi: 10.1111/j.1939-1676.1993.tb01013.x. [DOI] [PubMed] [Google Scholar]
  • 24.Moore MJ, Erlichman C. Pharmacology of anticancer drugs. In: Tannock IF, Hill RP, editors. The Basic Science of Oncology. 3rd ed. New York: McGraw-Hill Health Professions Division NY; 1998. pp. 370–391. [Google Scholar]
  • 25.Ike O, Shimizu Y, Wada R, Hyon SH, Ikada Y. Controlled cisplatin delivery system using poly(D,L-lactic acid) Biomaterials. 1992;13:230–234. doi: 10.1016/0142-9612(92)90189-U. [DOI] [PubMed] [Google Scholar]
  • 26.Boisdron-Celle M, Menei P, Benoit JP. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J Pharm Pharmacol. 1995;47:108–114. doi: 10.1111/j.2042-7158.1995.tb05760.x. [DOI] [PubMed] [Google Scholar]
  • 27.Dubey RR, Parikh JR, Parikh RR. Effect of heating temperature and time on pharmaceutical characteristics of albumin microspheres containing 5-fluorouracil. AAPS PharmSciTech. 2003;4:E4–E4. doi: 10.1208/pt040104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fu YJ, Shyu SS, Su FH, Yu PC. Development of biodegradable co-poly(D,L-lactic/glycolic acid) microspheres for the controlled release of 5-FU by the spray drying method colloids and surfaces. B Biointerfaces. 2002;25:269–279. doi: 10.1016/S0927-7765(01)00205-3. [DOI] [Google Scholar]
  • 29.Ozalp Y, Özdemir N, Kocagöz S, Hasirci V. Controlled release of Vancomycin from biodegradable microcapsules. J Microencapsul. 2001;18:89–110. doi: 10.1080/026520401750038638. [DOI] [PubMed] [Google Scholar]
  • 30.Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters. AAPS PharmSciTech. 2003;4:E13–E13. doi: 10.1208/pt040213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Giunchedi P, Conte U. Spray-drying as a preparation method of microparticulate drug delivery systems: an overview. STP Pharma Sciences. 1995;5:276–290. [Google Scholar]
  • 32.Gavini E, Sanna V, Juliano C, Giunchedi P. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of Ketoprofen. J Microencapsul. 2003;20:193–201. doi: 10.1080/0265204021000022752. [DOI] [PubMed] [Google Scholar]
  • 33.Giunchedi P, Gavini E, Bonacucina G, Palmieri GF. Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method. J Microencapsul. 2000;17:711–720. doi: 10.1080/02652040050161701. [DOI] [PubMed] [Google Scholar]
  • 34.Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. PLGA microspheres for the ocular delivery of a peptide drug: vancomycin. Emulsification/spray-drying as preparation method; in vitro/in vivo studies. Eur J Pharm Biopharm. 2004;57:207–212. doi: 10.1016/j.ejpb.2003.10.018. [DOI] [PubMed] [Google Scholar]
  • 35.Giunchedi P, Conti B, Puglisi G, Genta I, Conte U. Emulsion spray-drying for the preparation of albumin loaded PLGA microspheres. Drug Dev Ind Pharm. 2001;27:745–750. doi: 10.1081/DDC-100107331. [DOI] [PubMed] [Google Scholar]
  • 36.Edmundson IC. In: Advances in Pharmaceutical Sciences. Bean HS, Carless JE, Beckett AH, editors. New York, NY: Academic Press; 1967. [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES